Sphingosine 1-phosphate Receptor Modulator class drugs

7 results

  • fingolimod

    (FINGOLIMOD)
    Aurobindo Pharma Limited
    Fingolimod capsules are indicated for treating relapsing forms of multiple sclerosis (MS) in patients aged 10 and older, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
    Medication Details
    Drug Interactions

  • fingolimod

    (Fingolimod)
    Camber Pharmaceuticals, Inc.
    Fingolimod capsules are indicated for treating relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in patients aged 10 years and older.
    Medication Details
    Drug Interactions

  • fingolimod

    (Fingolimod)
    Dr. Reddy's Laboratories Inc
    Fingolimod capsules are indicated for treating relapsing forms of multiple sclerosis (MS) in patients aged 10 and older, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
    Medication Details
    Drug Interactions

  • fingolimod

    (FINGOLIMOD)
    Quallent Pharmaceuticals Health LLC
    Fingolimod capsules are indicated for the treatment of relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in patients aged 10 and older.
    Medication Details
    Drug Interactions

  • mayzent

    (siponimod)
    Novartis Pharmaceuticals Corporation
    MAYZENT is indicated for treating relapsing forms of multiple sclerosis in adults, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
    Medication Details
    Drug Interactions

  • ponvory

    (Ponesimod)
    Janssen Pharmaceuticals, Inc.
    PONVORY is indicated for treating relapsing forms of multiple sclerosis (MS) in adults, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
    Medication Details

  • ponvory

    (Ponesimod)
    Vanda Pharmaceuticals Inc.
    PONVORY is indicated for treating relapsing forms of multiple sclerosis (MS) in adults, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
    Medication Details